USP22 and cancer: Knock-down and overexpression studies in cancer cell lines suggest that Usp22 may promote cancer through the positive regulation of well-known oncogenes including BMI1 [5], c-MYC [6], SIRT1 [7], cyclin B1 [8], and KDM1A [9], mainly through the regulation of cell cycle progression.